Search
Ciproquazone
go.drugbank.com/drugs/DB21064ExperimentalCiproquazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Ciproquazone is a anti-inflammatory analgesic, phenylbutazone derivative.
Feclobuzone
go.drugbank.com/drugs/DB21131ExperimentalFeclobuzone is a small molecule drug. The usage of the INN stem '-zone' in the name indicates that Feclobuzone is a anti-inflammatory analgesic, phenylbutazone derivative.
Riodipine
go.drugbank.com/drugs/DB21310ExperimentalRiodipine is a small molecule drug. The usage of the INN stem '-dipine' in the name indicates that Riodipine is a calcium channel blocker, nifedipine derivative.
Fenclofenac
go.drugbank.com/drugs/DB21391ExperimentalFenclofenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Fenclofenac is a anti-inflammatory agent, ibufenac derivative.
Pirinidazole
go.drugbank.com/drugs/DB21413ExperimentalPirinidazole is a small molecule drug. The usage of the INN stem '-nidazole' in the name indicates that Pirinidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
Tifurac
go.drugbank.com/drugs/DB21415ExperimentalTifurac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tifurac is a anti-inflammatory agent, ibufenac derivative.
Canocapavir
go.drugbank.com/drugs/DB21570ExperimentalCanocapavir is a small molecule drug. The usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor.
Emzeltrectinib
go.drugbank.com/drugs/DB21605ExperimentalEmzeltrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Emzeltrectinib is a tropomyosin receptor kinase (TRK) inhibitor.
Fosifloxuridine nafalbenamide
go.drugbank.com/drugs/DB14859InvestigationalFosifloxuridine nafalbenamide is under investigation in clinical trial NCT03428958 (A Safety Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment).
Ieramilimab
go.drugbank.com/drugs/DB16419InvestigationalIeramilimab is under investigation in clinical trial NCT02460224 (Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.).